{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:56:49Z","timestamp":1790582209720,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.abd.2026.501439","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:26:16Z","timestamp":1786033576000},"page":"501439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ixekizumab for genetically confirmed type 5 pityriasis rubra pilaris with a CARD14 p.Met119Thr variant"],"prefix":"10.1016","volume":"101","author":[{"given":"Omer Faruk","family":"Tolun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-5917","authenticated-orcid":false,"given":"Yusuf","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhan","family":"Engin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501439_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2230.1980.tb01676.x","article-title":"Pityriasis rubra pilaris","volume":"5","author":"Griffiths","year":"1980","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.abd.2026.501439_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ajhg.2012.05.010","article-title":"Familial pityriasis rubra pilaris is caused by mutations in CARD14","volume":"91","author":"Fuchs-Telem","year":"2012","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.abd.2026.501439_bib0015","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/ced\/llae019","article-title":"A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab","volume":"49","author":"Ouyang","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2026.501439_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.abd.2025.501283","article-title":"Type IV pityriasis rubra pilaris treated with ixekizumab","volume":"101","author":"Ferreirinha","year":"2026","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501439_bib0025","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/bjd.15462","article-title":"Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14","volume":"178","author":"Lwin","year":"2018","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501439_bib0030","article-title":"Case report: successful treatment with biologics in a pediatric patient with a severe inflammatory skin disease and novel CARD14 mutation","volume":"11","author":"Nied\u017awied\u017a","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.abd.2026.501439_bib0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaad.2023.08.057","article-title":"Biologic treatment options for pityriasis rubra pilaris: an evidence-based systematic review","volume":"89","author":"Sood","year":"2023","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501439_bib0040","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.389","article-title":"Severe atypical juvenile pityriasis rubra pilaris diagnosed in adulthood with a dramatic improvement with ustekinumab","volume":"4","author":"McCarthy","year":"2024","journal-title":"Skin Health Dis."},{"key":"10.1016\/j.abd.2026.501439_bib0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","article-title":"Evaluation of ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial","volume":"156","author":"Haynes","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2026.501439_bib0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.abd.2023.07.009","article-title":"Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab","volume":"99","author":"Vieira Granja","year":"2024","journal-title":"An Bras Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T07:25:12Z","timestamp":1790580312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0365059626001522"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501439","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ixekizumab for genetically confirmed type 5 pityriasis rubra pilaris with a CARD14 p.Met119Thr variant","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501439"}}